交易中 07-21 11:07:06 美东时间
-0.080
-0.33%
USA Compression Partners (NYSE:USAC) declares $0.525/share quarterly dividend, in line with previous. Forward yield 8.69% Payable Aug. 8; for shareholders of record July 28; ex-div July 28. See USAC D...
07-18 20:49
United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE:UAMY), announced today that it has been stealthily reacquiring mining claims and real property since earlier this year, immediately
07-03 20:08
The latest update is out from USA Compression ( ($USAC) ). USA Compression Part...
06-21 05:33
An announcement from USA Compression ( ($USAC) ) is now available. On June 4, U...
05-31 05:07
USA Compression ( ($USAC) ) has issued an announcement. On May 21, senior manag...
05-17 04:52
Major earnings expected before the bell on Tuesday include: Archer-Daniels-Midland (ADM) Datadog (DDOG) Duke Energy (DUK) Marathon Petroleum (MPC) MPLX (MPLX) Other earnings slated for release before ...
05-06 06:00
USA Compression Partners (NYSE:USAC) declares $0.525/share quarterly dividend, in line with previous. Forward yield 8.33% Payable May 9; for shareholders of record April 28; ex-div April 28. See USAC ...
04-18 19:15
"The Critical Minerals and ZEO Company"DALLAS, TX / ACCESS Newswire / April 11, 2025 / United States Antimony Corporation ("USAC," "U.S. Antimony," or the "Company"), (NYSE:UAMY), the only vertically integrated antimony
04-11 20:05
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM:维持CervoMed Inc.(CRVO)"买入"评级,目标价从7美元升至15美元</p> <p>• Oppenheimer:维持Trevi Therapeutics(TRVI)"跑赢大市"评级,目标价从
03-12 11:01
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.:维持Karyopharm Therape
02-27 11:06